-
Mashup Score: 0EHRA 2024: Cryocure-VT trial results “promising” for VT ablation - 29 day(s) ago
A trial of technology using ultra-low temperature cryoablation (ULTC) has shown that the technique eliminated clinical ventricular tachycardia (VT) in 94% of patients, results presented at EHRA 2024 show.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2EHRA 2024: Sphere-360 study reports first-in-man results of Medtronic PFA catheter - Cardiac Rhythm News - 29 day(s) ago
Interim first-in-human clinical safety and efficacy results for Medtronic’s Sphere-360 investigational single-shot mapping and PFA catheter, for treatment of patients with paroxysmal AF were presented as a late-breaking clinical trial at EHRA 2024.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
An international consensus statement on how to treat atrial fibrillation (AF) with catheter or surgical ablation has been published today in EP Europace and presented at the European Heart Rhythm Association (EHRA) 2024 congress (7–9 April, Berlin, Germany). Lead author Stylianos Tzeis (Mitera Hospital, Athens, Greece), said: “Ablation is the most effective way to prevent […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
A randomised trial investigating preventive ablation of a potential arrhythmogenic substrate associated with coronary CTO in patients at high risk of ventricular arrhythmias has found that this approach may reduce the risk of appropriate ICD therapy and unplanned hospitalisation.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2High-power short-duration ablation protocol “reduces procedure times” - Cardiac Rhythm News - 1 month(s) ago
High-power short-duration ablation results in significantly shorter procedure times without affecting procedural efficacy and safety among patients undergoing ablation for atrial fibrillation (AF). This is according to the findings of a single-centre study investigating the impact of high-density mapping alongside high-power short-duration ablation protocols on the timing, efficacy and safety of the procedures, in which […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 26Varipulse PFA system receives CE mark - 2 month(s) ago
Biosense Webster has announced the receipt of European CE mark approval for the Varipulse platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA).
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0AHA acknowledges potential and pitfalls for AI in cardiovascular medicine - Cardiac Rhythm News - 2 month(s) ago
A scientific statement published by the American Heart Association (AHA) in Circulation today acknowledges the potential “transformative” impact of the technology on cardiovascular medicine, but challenges remain in its development, the authors of the paper state. The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Advertorial: Arrival of PFA “may widen accessibility” of ablation for AF patients - Cardiac Rhythm News - 2 month(s) ago
This advertorial is sponsored by Biosense Webster The field of catheter ablation for atrial fibrillation (AF) is evolving. The development of pulsed field ablation (PFA), as well as advances in established technologies such as radiofrequency (RF) ablation, help catheter ablation to offer a promising confluence of safety, efficacy and efficiency in arrhythmia treatment.1 Given the global […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 50Boston Scientific’s Farapulse PFA system gains US FDA approval - 3 month(s) ago
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Farapulse pulsed field ablation (PFA) system.
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 100Abbott joins the pulsed field ablation party - Cardiac Rhythm News - 4 month(s) ago
Abbott has announced the first global procedures have been conducted using the company’s new Volt pulsed field ablation system to treat patients with arrhythmias such as atrial fibrillation (AF).
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
Results of Cryocure-VT, presented by @atulverma_md demonstrated the safety and efficacy of ultra-low temperature cryoablation using the @AtriCure system for the treatment of recurrent monomorphic VTs https://t.co/VKI6TUjswn